In situ forming parenteral depot systems based on poly(ethylene carbonate): Effect of polymer molecular weight on model protein release

[Display omitted] The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutics and biopharmaceutics Vol. 85; no. 3; pp. 1245 - 1249
Main Authors Chu, Dafeng, Curdy, Catherine, Riebesehl, Bernd, Beck-Broichsitter, Moritz, Kissel, Thomas
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.11.2013
Subjects
Online AccessGet full text
ISSN0939-6411
1873-3441
1873-3441
DOI10.1016/j.ejpb.2013.05.020

Cover

Abstract [Display omitted] The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200kDa (PEC200) in DMSO (15%, w/w) in 2days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier.
AbstractList [Display omitted] The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200kDa (PEC200) in DMSO (15%, w/w) in 2days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier.
The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200 kDa (PEC200) in DMSO (15%, w/w) in 2 days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6 days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier.The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200 kDa (PEC200) in DMSO (15%, w/w) in 2 days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6 days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier.
The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200 kDa (PEC200) in DMSO (15%, w/w) in 2 days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6 days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier.
Author Beck-Broichsitter, Moritz
Chu, Dafeng
Kissel, Thomas
Curdy, Catherine
Riebesehl, Bernd
Author_xml – sequence: 1
  givenname: Dafeng
  surname: Chu
  fullname: Chu, Dafeng
  organization: Department of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany
– sequence: 2
  givenname: Catherine
  surname: Curdy
  fullname: Curdy, Catherine
  organization: Novartis Pharma AG, Basel, Switzerland
– sequence: 3
  givenname: Bernd
  surname: Riebesehl
  fullname: Riebesehl, Bernd
  organization: Novartis Pharma AG, Basel, Switzerland
– sequence: 4
  givenname: Moritz
  surname: Beck-Broichsitter
  fullname: Beck-Broichsitter, Moritz
  organization: Department of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany
– sequence: 5
  givenname: Thomas
  surname: Kissel
  fullname: Kissel, Thomas
  email: kissel@staff.uni-marburg.de
  organization: Department of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23791717$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFu1DAQhi1URLcLL8AB-VgOCXbixAnigqoClSpxgbM1scetV44dbG_RPgGvTZYtHDj0NBrp-2ak_78gZyEGJOQ1ZzVnvH-3q3G3THXDeFuzrmYNe0Y2fJBt1QrBz8iGje1Y9YLzc3KR844xJmQ3vCDnTStHLrnckF83gWZX9tTGNLtwRxdIGAom8NTgEgvNh1xwznSCjIbGQJfoD5dY7g8eA1INaYoBCr59T6-tRV1otH-YGROdo0e995DoT3R39-Xoz9Ggp0uKBV2gCT2ul1-S5xZ8xlePc0u-f7r-dvWluv36-ebq422l264vFfSaM9M1VloLU9-DYWIUnTEGDNphMpoNorPD0DENYl251ABWGN4wkFa0W3J5urv-_7HHXNTsskbvIWDcZ8VF33EpxzW6LXnziO6nGY1akpshHdTf8FagOQE6xZwT2n8IZ-rYkNqpY0Pq2JBinVobWqXhP0m7AsXFUBI4_7T64aTiGtCDw6Sydhg0GpfW3JWJ7in9N7Hgr48
CitedBy_id crossref_primary_10_1016_j_polymdegradstab_2018_11_018
crossref_primary_10_3390_pharmaceutics13050605
crossref_primary_10_1016_j_progpolymsci_2018_01_006
crossref_primary_10_1016_j_ejpb_2017_02_011
crossref_primary_10_1080_13102818_2015_1063453
crossref_primary_10_1016_j_msec_2018_05_046
crossref_primary_10_3390_pharmaceutics15102401
crossref_primary_10_1016_j_ijbiomac_2018_11_098
crossref_primary_10_1016_j_matdes_2015_09_138
crossref_primary_10_1016_j_ijpharm_2016_07_075
crossref_primary_10_1016_j_jconrel_2014_03_048
crossref_primary_10_1016_j_ijpharm_2022_121603
Cites_doi 10.1016/j.jconrel.2010.08.020
10.1016/S0168-3659(97)00097-7
10.1016/j.ejpb.2010.07.009
10.1016/j.ejpb.2004.03.003
10.1016/S0168-3659(01)00417-5
10.1002/mabi.201000496
10.1016/0168-3659(94)00083-7
10.1016/j.jconrel.2012.04.016
10.1016/j.biomaterials.2005.09.017
10.1016/j.jconrel.2005.10.005
10.1016/j.biomaterials.2008.09.038
10.1016/j.jconrel.2003.08.010
10.1016/j.jconrel.2005.09.038
10.1002/jbm.a.32724
10.1016/j.ijpharm.2003.06.002
10.1002/jps.21415
10.1016/j.biomaterials.2009.03.033
10.1007/s11095-009-9969-0
10.1016/j.jconrel.2010.01.001
10.1016/j.ejps.2008.03.004
10.1016/S0168-3659(98)00158-8
10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
ContentType Journal Article
Copyright 2013 Elsevier B.V.
Copyright © 2013 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2013 Elsevier B.V.
– notice: Copyright © 2013 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ejpb.2013.05.020
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3441
EndPage 1249
ExternalDocumentID 23791717
10_1016_j_ejpb_2013_05_020
S0939641113002282
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SES
SEW
SPCBC
SSP
SSU
SSZ
T5K
TEORI
UNMZH
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
ID FETCH-LOGICAL-c356t-a6c10d52f7ffab66ad04945dddadef8bdc0845f8850ca4bdc17caaf4d120a7f43
IEDL.DBID AIKHN
ISSN 0939-6411
1873-3441
IngestDate Fri Sep 05 13:21:37 EDT 2025
Thu Apr 03 06:59:45 EDT 2025
Tue Jul 01 00:58:36 EDT 2025
Thu Apr 24 22:59:31 EDT 2025
Fri Feb 23 02:28:04 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Drug release
Water swelling
Poly(ethylene carbonate)
Surface-eroding polymers
Initial burst
In situ forming depots
Language English
License Copyright © 2013 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c356t-a6c10d52f7ffab66ad04945dddadef8bdc0845f8850ca4bdc17caaf4d120a7f43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23791717
PQID 1465177909
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1465177909
pubmed_primary_23791717
crossref_primary_10_1016_j_ejpb_2013_05_020
crossref_citationtrail_10_1016_j_ejpb_2013_05_020
elsevier_sciencedirect_doi_10_1016_j_ejpb_2013_05_020
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-11-01
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle European journal of pharmaceutics and biopharmaceutics
PublicationTitleAlternate Eur J Pharm Biopharm
PublicationYear 2013
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Packhaeuser, Schnieders, Oster, Kissel (b0050) 2004; 58
Patel, Carlson, Solorio, Exner (b0095) 2010; 94
Astaneh, Erfan, Moghimi, Mobedi (b0100) 2009; 98
Stoll, Nimmerfall, Acemoglu, Bodmer, Bantle, Muller, Mahl, Kolopp, Tullberg (b0005) 2001; 76
Acemoglu, Nimmerfall, Bantle, Stoll (b0035) 1997; 49
Patel, Solorio, Wu, Krupka, Exner (b0090) 2010; 147
Solorio, Babin, Patel, Mach, Azar, Exner (b0085) 2010; 143
Zhang, Kuijer, Bulstra, Grijpma, Feijen (b0020) 2006; 27
Luan, Bodmeier (b0080) 2006; 110
Bege, Renette, Jansch, Reul, Merkel, Petersen, Curdy, Müller, Kissel (b0040) 2011; 11
Eliaz, Kost (b0105) 2000; 50
Dadsetan, Christenson, Unger, Ausborn, Kissel, Hiltner, Andersona (b0015) 2003; 93
Bat, van Kooten, Feijen, Grijpma (b0030) 2009; 30
McHugh (b0070) 2005; 109
Kempe, Mäder (b0055) 2012; 161
Inoue, Tsuruta, Takada, Miyazaki, Kambe, Takaoka (b0060) 1975; 26
Chapanian, Tse, Pang, Amsden (b0025) 2009; 30
Schoenhammer, Petersen, Guethlein, Goepferich (b0065) 2009; 26
Graham, Brodbeck, McHugh (b0075) 1999; 58
Kranz, Bodmeier (b0115) 2008; 34
Lambert, Peck (b0110) 1995; 33
Liu, Kemmer, Keim, Curdy, Petersen, Kissel (b0045) 2010; 76
Acemoglu (b0010) 2004; 277
Bat (10.1016/j.ejpb.2013.05.020_b0030) 2009; 30
McHugh (10.1016/j.ejpb.2013.05.020_b0070) 2005; 109
Liu (10.1016/j.ejpb.2013.05.020_b0045) 2010; 76
Schoenhammer (10.1016/j.ejpb.2013.05.020_b0065) 2009; 26
Acemoglu (10.1016/j.ejpb.2013.05.020_b0035) 1997; 49
Kranz (10.1016/j.ejpb.2013.05.020_b0115) 2008; 34
Packhaeuser (10.1016/j.ejpb.2013.05.020_b0050) 2004; 58
Chapanian (10.1016/j.ejpb.2013.05.020_b0025) 2009; 30
Luan (10.1016/j.ejpb.2013.05.020_b0080) 2006; 110
Patel (10.1016/j.ejpb.2013.05.020_b0090) 2010; 147
Patel (10.1016/j.ejpb.2013.05.020_b0095) 2010; 94
Graham (10.1016/j.ejpb.2013.05.020_b0075) 1999; 58
Eliaz (10.1016/j.ejpb.2013.05.020_b0105) 2000; 50
Inoue (10.1016/j.ejpb.2013.05.020_b0060) 1975; 26
Lambert (10.1016/j.ejpb.2013.05.020_b0110) 1995; 33
Solorio (10.1016/j.ejpb.2013.05.020_b0085) 2010; 143
Zhang (10.1016/j.ejpb.2013.05.020_b0020) 2006; 27
Kempe (10.1016/j.ejpb.2013.05.020_b0055) 2012; 161
Acemoglu (10.1016/j.ejpb.2013.05.020_b0010) 2004; 277
Astaneh (10.1016/j.ejpb.2013.05.020_b0100) 2009; 98
Stoll (10.1016/j.ejpb.2013.05.020_b0005) 2001; 76
Dadsetan (10.1016/j.ejpb.2013.05.020_b0015) 2003; 93
Bege (10.1016/j.ejpb.2013.05.020_b0040) 2011; 11
References_xml – volume: 58
  start-page: 445
  year: 2004
  end-page: 455
  ident: b0050
  article-title: In situ forming parenteral drug delivery systems: an overview
  publication-title: Eur. J. Pharm. Biopharm.
– volume: 98
  start-page: 135
  year: 2009
  end-page: 145
  ident: b0100
  article-title: Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior
  publication-title: J. Pharm. Sci.
– volume: 26
  start-page: 257
  year: 1975
  end-page: 267
  ident: b0060
  article-title: Synthesis and thermal degradation of carbon dioxide–epoxide copolymer
  publication-title: Appl. Polym. Symp.
– volume: 143
  start-page: 183
  year: 2010
  end-page: 190
  ident: b0085
  article-title: Noninvasive characterization of in situ forming implants using diagnostic ultrasound
  publication-title: J. Control. Release
– volume: 34
  year: 2008
  ident: b0115
  article-title: Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles
  publication-title: Eur. J. Pharm. Sci.
– volume: 49
  start-page: 263
  year: 1997
  end-page: 276
  ident: b0035
  article-title: Poly(ethylene carbonate)s, Part I: Syntheses and structural effects on biodegradation
  publication-title: J. Control. Release
– volume: 30
  start-page: 3652
  year: 2009
  end-page: 3661
  ident: b0030
  article-title: Macrophage-mediated erosion of gamma irradiated poly(trimethylene carbonate) films
  publication-title: Biomaterials
– volume: 147
  start-page: 350
  year: 2010
  end-page: 358
  ident: b0090
  article-title: Effect of injection site on in situ implant formation and drug release in vivo
  publication-title: J. Control. Release
– volume: 11
  start-page: 897
  year: 2011
  end-page: 904
  ident: b0040
  article-title: Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with “Stealth” potential
  publication-title: Macromol. Biosci.
– volume: 109
  start-page: 211
  year: 2005
  end-page: 221
  ident: b0070
  article-title: The role of polymer membrane formation in sustained release drug delivery systems
  publication-title: J. Control. Release
– volume: 161
  start-page: 668
  year: 2012
  end-page: 679
  ident: b0055
  article-title: In situ forming implants – an attractive formulation principle for parenteral depot formulations
  publication-title: J. Control. Release
– volume: 30
  start-page: 295
  year: 2009
  end-page: 306
  ident: b0025
  article-title: The role of oxidation and enzymatic hydrolysis on the in vivo degradation of trimethylene carbonate based photocrosslinkable elastomers
  publication-title: Biomaterials
– volume: 58
  start-page: 233
  year: 1999
  end-page: 245
  ident: b0075
  article-title: Phase inversion dynamics of PLGA solutions related to drug delivery
  publication-title: J. Control. Release
– volume: 33
  start-page: 189
  year: 1995
  end-page: 195
  ident: b0110
  article-title: Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins
  publication-title: J. Control. Release
– volume: 110
  start-page: 266
  year: 2006
  end-page: 272
  ident: b0080
  article-title: Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems
  publication-title: J. Control. Release
– volume: 93
  start-page: 259
  year: 2003
  end-page: 270
  ident: b0015
  article-title: In vivo biocompatibility and biodegradation of poly(ethylene carbonate)
  publication-title: J. Control. Release
– volume: 76
  start-page: 209
  year: 2001
  end-page: 225
  ident: b0005
  article-title: Poly(ethylene carbonate)s: Part II. Degradation mechanisms and parenteral delivery of bioactive agents
  publication-title: J. Control. Release
– volume: 277
  start-page: 133
  year: 2004
  end-page: 139
  ident: b0010
  article-title: Chemistry of polymer biodegradation and implications on parenteral drug delivery
  publication-title: Int. J. Pharm.
– volume: 50
  start-page: 388
  year: 2000
  end-page: 396
  ident: b0105
  article-title: Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins
  publication-title: J. Biomed. Mater. Res.
– volume: 27
  start-page: 1741
  year: 2006
  end-page: 1748
  ident: b0020
  article-title: The in vivo and in vitro degradation behavior of poly(trimethylene carbonate)
  publication-title: Biomaterials
– volume: 76
  start-page: 222
  year: 2010
  end-page: 229
  ident: b0045
  article-title: Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: a feasibility study
  publication-title: Eur. J. Pharm. Biopharm.
– volume: 94
  start-page: 476
  year: 2010
  end-page: 484
  ident: b0095
  article-title: Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems
  publication-title: J. Biomed. Mater. Res. A
– volume: 26
  start-page: 2568
  year: 2009
  end-page: 2577
  ident: b0065
  article-title: Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots
  publication-title: Pharm. Res.
– volume: 147
  start-page: 350
  year: 2010
  ident: 10.1016/j.ejpb.2013.05.020_b0090
  article-title: Effect of injection site on in situ implant formation and drug release in vivo
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2010.08.020
– volume: 49
  start-page: 263
  year: 1997
  ident: 10.1016/j.ejpb.2013.05.020_b0035
  article-title: Poly(ethylene carbonate)s, Part I: Syntheses and structural effects on biodegradation
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(97)00097-7
– volume: 76
  start-page: 222
  year: 2010
  ident: 10.1016/j.ejpb.2013.05.020_b0045
  article-title: Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: a feasibility study
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2010.07.009
– volume: 58
  start-page: 445
  year: 2004
  ident: 10.1016/j.ejpb.2013.05.020_b0050
  article-title: In situ forming parenteral drug delivery systems: an overview
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2004.03.003
– volume: 76
  start-page: 209
  year: 2001
  ident: 10.1016/j.ejpb.2013.05.020_b0005
  article-title: Poly(ethylene carbonate)s: Part II. Degradation mechanisms and parenteral delivery of bioactive agents
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(01)00417-5
– volume: 11
  start-page: 897
  year: 2011
  ident: 10.1016/j.ejpb.2013.05.020_b0040
  article-title: Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with “Stealth” potential
  publication-title: Macromol. Biosci.
  doi: 10.1002/mabi.201000496
– volume: 33
  start-page: 189
  year: 1995
  ident: 10.1016/j.ejpb.2013.05.020_b0110
  article-title: Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins
  publication-title: J. Control. Release
  doi: 10.1016/0168-3659(94)00083-7
– volume: 161
  start-page: 668
  year: 2012
  ident: 10.1016/j.ejpb.2013.05.020_b0055
  article-title: In situ forming implants – an attractive formulation principle for parenteral depot formulations
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2012.04.016
– volume: 27
  start-page: 1741
  year: 2006
  ident: 10.1016/j.ejpb.2013.05.020_b0020
  article-title: The in vivo and in vitro degradation behavior of poly(trimethylene carbonate)
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2005.09.017
– volume: 110
  start-page: 266
  year: 2006
  ident: 10.1016/j.ejpb.2013.05.020_b0080
  article-title: Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2005.10.005
– volume: 30
  start-page: 295
  year: 2009
  ident: 10.1016/j.ejpb.2013.05.020_b0025
  article-title: The role of oxidation and enzymatic hydrolysis on the in vivo degradation of trimethylene carbonate based photocrosslinkable elastomers
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2008.09.038
– volume: 93
  start-page: 259
  year: 2003
  ident: 10.1016/j.ejpb.2013.05.020_b0015
  article-title: In vivo biocompatibility and biodegradation of poly(ethylene carbonate)
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2003.08.010
– volume: 109
  start-page: 211
  year: 2005
  ident: 10.1016/j.ejpb.2013.05.020_b0070
  article-title: The role of polymer membrane formation in sustained release drug delivery systems
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2005.09.038
– volume: 94
  start-page: 476
  year: 2010
  ident: 10.1016/j.ejpb.2013.05.020_b0095
  article-title: Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems
  publication-title: J. Biomed. Mater. Res. A
  doi: 10.1002/jbm.a.32724
– volume: 277
  start-page: 133
  year: 2004
  ident: 10.1016/j.ejpb.2013.05.020_b0010
  article-title: Chemistry of polymer biodegradation and implications on parenteral drug delivery
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2003.06.002
– volume: 26
  start-page: 257
  year: 1975
  ident: 10.1016/j.ejpb.2013.05.020_b0060
  article-title: Synthesis and thermal degradation of carbon dioxide–epoxide copolymer
  publication-title: Appl. Polym. Symp.
– volume: 98
  start-page: 135
  year: 2009
  ident: 10.1016/j.ejpb.2013.05.020_b0100
  article-title: Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.21415
– volume: 30
  start-page: 3652
  year: 2009
  ident: 10.1016/j.ejpb.2013.05.020_b0030
  article-title: Macrophage-mediated erosion of gamma irradiated poly(trimethylene carbonate) films
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.03.033
– volume: 26
  start-page: 2568
  year: 2009
  ident: 10.1016/j.ejpb.2013.05.020_b0065
  article-title: Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-009-9969-0
– volume: 143
  start-page: 183
  year: 2010
  ident: 10.1016/j.ejpb.2013.05.020_b0085
  article-title: Noninvasive characterization of in situ forming implants using diagnostic ultrasound
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2010.01.001
– volume: 34
  year: 2008
  ident: 10.1016/j.ejpb.2013.05.020_b0115
  article-title: Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2008.03.004
– volume: 58
  start-page: 233
  year: 1999
  ident: 10.1016/j.ejpb.2013.05.020_b0075
  article-title: Phase inversion dynamics of PLGA solutions related to drug delivery
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(98)00158-8
– volume: 50
  start-page: 388
  year: 2000
  ident: 10.1016/j.ejpb.2013.05.020_b0105
  article-title: Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins
  publication-title: J. Biomed. Mater. Res.
  doi: 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
SSID ssj0004758
Score 2.1541903
Snippet [Display omitted] The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC)...
The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1245
SubjectTerms Animals
Biocompatible Materials - chemistry
Cattle
Chemistry, Pharmaceutical - methods
Diffusion
Drug Delivery Systems
Drug release
Drug Stability
Hydrogen-Ion Concentration
In situ forming depots
Infusions, Parenteral
Initial burst
Microscopy, Electron, Scanning
Molecular Weight
Particle Size
Poly(ethylene carbonate)
Polyethylenes - chemistry
Polymers - chemistry
Serum Albumin, Bovine - chemistry
Solvents - chemistry
Surface-eroding polymers
Viscosity
Water - chemistry
Water swelling
Title In situ forming parenteral depot systems based on poly(ethylene carbonate): Effect of polymer molecular weight on model protein release
URI https://dx.doi.org/10.1016/j.ejpb.2013.05.020
https://www.ncbi.nlm.nih.gov/pubmed/23791717
https://www.proquest.com/docview/1465177909
Volume 85
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbp5tJL6bubtmEKJbQ07lq25EdvITRsWhoCTSA3IUsybEjsZddL2Euu_dudkewshTaHHi00stCMNSN55vsYe1_qVJa6chF6qzwSqOKoLG0SxaKqLcEXVYJqh3-cZNNz8e1CXmyxw6EWhtIq-70_7Ol-t-5bJv1qTuaz2eQnDlRmgqjSPYgL7sPbCbbIEds-OP4-PdmUR-aeppP6RyTQ186ENC93Oa8owyv1AJ5E-_13__Sv-NP7oaPH7FEfQMJBmOMTtuWap2zvNCBQr_fhbFNQtdyHPTjdYFOvn7Ffxw0sZ90KKFZFrwWUgE5ri0NajMU7CNDOSyD3ZqFtYN5erT841Cf6JwdGLyq6cHcfv0BAPoa29n2u3QKuB7JduPFXriTvuXbA40HMGiCOFhz5OTs_-np2OI16LobIpDLrIp0ZHluZ1Hld6yrLtCVgGWmt1dbVRWVNXAhZF4WMjRb4yHOjdS0sT2Kd1yJ9wUZN27hXDHiSOFcap1NbCMO1LnDZY2tzVJ61VTZmfNCAMj1QOfFlXKkhI-1SkdYUaU3FUqH4mH26k5kHmI57e8tBseoPY1PoR-6VezdYgcKvkH6t6Ma1qyUdoCQn6MZyzF4G87ibR5LmeCbm-c5_vvU1e0hPoQDyDRt1i5V7i5FQV-2yB59v-W5v778BYJIK-g
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcoAL4s1CgUFCFYiGzcOOE26ootpCW1ViK_Vm-Slt1Sar3ayqvXDlb-Oxk66QoAeOSWYcyzOZGTsz3xDyrpYFq6WyifdWPKFexEldmzxJqXIG4YsUxdrh45Nycka_nbPzLbI_1MJgWmVv-6NND9a6vzPuV3M8n83GP_xAdUmxVXoAcfF2-A5lBce8vk8_N3kelIcmnUidIHlfOROTvOzFXGF-VxHgO7Hp99-907-iz-CFDh6Q-334CF_iDB-SLds8IrunEX96vQfTTTnVcg924XSDTL1-TH4dNrCcdSvASNX7LMD0c1xZP6TxkXgHEdh5CejcDLQNzNvL9Xvrpem9kwUtFwqP2-2HzxBxj6F1gebKLuBqaLUL1-HAFflDpx0IaBCzBrBDix_5CTk7-DrdnyR9J4ZEF6zsElnqLDUsd9w5qcpSGoSVYcYYaayrlNFpRZmrKpZqSf1lxrWUjposTyV3tHhKtpu2sc8JZHluba2tLExFdSZl5Zc9NYZ7YRqjyhHJBgkI3cOUY7eMSzHko10IlJpAqYmUCc8-Ih9veOYRpONWajYIVvyhasJ7kVv53g5aIPw3iD9WZGPb1RK3TyxD4MZ6RJ5F9biZR15wvyPO-Iv_fOsbcncyPT4SR4cn31-Se_gklkLukO1usbKvfEzUqddB538Dq5sLxQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+situ+forming+parenteral+depot+systems+based+on+poly%28ethylene+carbonate%29%3A+effect+of+polymer+molecular+weight+on+model+protein+release&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=Chu%2C+Dafeng&rft.au=Curdy%2C+Catherine&rft.au=Riebesehl%2C+Bernd&rft.au=Beck-Broichsitter%2C+Moritz&rft.date=2013-11-01&rft.issn=1873-3441&rft.eissn=1873-3441&rft.volume=85&rft.issue=3+Pt+B&rft.spage=1245&rft_id=info:doi/10.1016%2Fj.ejpb.2013.05.020&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon